SIGA Technologies, Inc. (NASDAQ:SIGA – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock investors bought 1,200 call options on the company. This represents an increase of approximately 1,438% compared to the average volume of 78 call options.
Hedge Funds Weigh In On SIGA Technologies
A number of hedge funds have recently bought and sold shares of SIGA. Hotchkis & Wiley Capital Management LLC lifted its holdings in SIGA Technologies by 152.6% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock worth $13,827,000 after buying an additional 1,237,620 shares during the last quarter. Foundry Partners LLC bought a new position in SIGA Technologies during the third quarter worth $2,801,000. AltraVue Capital LLC lifted its stake in SIGA Technologies by 14.1% during the fourth quarter. AltraVue Capital LLC now owns 2,639,524 shares of the company’s stock worth $15,864,000 after purchasing an additional 326,630 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in SIGA Technologies by 237.7% in the fourth quarter. Renaissance Technologies LLC now owns 417,436 shares of the company’s stock worth $2,509,000 after purchasing an additional 293,836 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in SIGA Technologies by 11.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,126,065 shares of the company’s stock valued at $12,777,000 after purchasing an additional 217,926 shares during the last quarter. 55.40% of the stock is currently owned by institutional investors and hedge funds.
SIGA Technologies Stock Down 0.3 %
Shares of SIGA opened at $5.74 on Thursday. SIGA Technologies has a 52-week low of $5.16 and a 52-week high of $12.83. The firm has a market cap of $410.05 million, a price-to-earnings ratio of 4.78 and a beta of 0.98. The business’s 50 day moving average is $5.94 and its two-hundred day moving average is $6.57.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Articles
- Five stocks we like better than SIGA Technologies
- How to Invest in Insurance Companies: A Guide
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Why is the Ex-Dividend Date Significant to Investors?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Stock Splits, Do They Really Impact Investors?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.